{"Abstract": [0], "Since": [1], "2002,": [2], "beta": [3], "coronaviruses": [4], "(CoV)": [5], "have": [6], "caused": [7], "three": [8], "zoonotic": [9], "outbreaks,": [10], "SARS-CoV": [11, 84, 94], "in": [12, 15, 22], "2002\u20132003,": [13], "MERS-CoV": [14], "2012,": [16], "and": [17, 68, 75, 106, 134], "the": [18, 31, 52, 123], "newly": [19], "emerged": [20], "SARS-CoV-2": [21, 37, 58, 77, 98], "late": [23], "2019.": [24], "However,": [25], "little": [26], "is": [27, 51, 80], "currently": [28], "known": [29], "about": [30], "biology": [32], "of": [33, 93, 132], "SARS-CoV-2.": [34, 137], "Here,": [35], "using": [36, 103], "S": [38, 78, 95, 99], "protein": [39, 79], "pseudovirus": [40], "system,": [41], "we": [42], "confirm": [43], "that": [44, 57, 65, 76, 114], "human": [45], "angiotensin": [46], "converting": [47], "enzyme": [48], "2": [49], "(hACE2)": [50], "receptor": [53], "for": [54, 73, 130, 136], "SARS-CoV-2,": [55], "find": [56], "enters": [59], "293/hACE2": [60], "cells": [61], "mainly": [62], "through": [63], "endocytosis,": [64], "PIKfyve,": [66], "TPC2,": [67], "cathepsin": [69], "L": [70], "are": [71], "critical": [72], "entry,": [74], "less": [81], "stable": [82], "than": [83], "S.": [85], "Polyclonal": [86], "anti-SARS": [87], "S1": [88], "antibodies": [89], "T62": [90], "inhibit": [91], "entry": [92], "but": [96], "not": [97, 120], "pseudovirions.": [100], "Further": [101], "studies": [102], "recovered": [104], "SARS": [105], "COVID-19": [107], "patients\u2019": [108], "sera": [109], "show": [110], "limited": [111], "cross-neutralization,": [112], "suggesting": [113], "recovery": [115], "from": [116], "one": [117], "infection": [118], "might": [119], "protect": [121], "against": [122], "other.": [124], "Our": [125], "results": [126], "present": [127], "potential": [128], "targets": [129], "development": [131], "drugs": [133], "vaccines": [135]}